InvestorsHub Logo
Followers 22
Posts 748
Boards Moderated 0
Alias Born 09/07/2016

Re: sts66 post# 182562

Friday, 03/22/2019 3:44:20 PM

Friday, March 22, 2019 3:44:20 PM

Post# of 429449
STS - you might be correct that BP won't want to run a long term study with V alone - without a statin. But, don't you think it's a crucial question - will Vascepa alone cause a significant decrease in CVD? I do

Aspirin studies are run all the time - it's generic. Plenty of statin studies were run with generics. Academics and the NIH will run studies using generics if they answer important questions. We may not get an answer anytime soon but if some folks on this board are correct AMRN could even make $ in a generic world.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News